Even at a young age, Dr. Christopher Mason was struck by the idea of spending the rest of his life unraveling the mysteries [more]
Science Daily Science News: Novel Drug Shuts Down Master Protein Key to Lymphoma Researchers have discovered how an [more]
Dr. Mason’s work with the SEQC and the ABRF was presented at the annual meeting of the ABRF, demonstrating the first [more]
Dr. Mason’s work in the human brain expression atlas was featured with the work of Dr. Sestan and Dr. Lein, and this work [more]
The overall goal of our research is to identify and characterize the pivotal functional elements in the human genome.
In the long-term, we aim to model the functional elements of the human genome across tissues and cells into complete networks; to then repair, re-engineer, or fortify these genetic networks.
Toward this end, we leverage computational genomics and parallelized bioinformatic algorithms to analyze data across integrative modalities of biology (genetic, epigenetic, transcriptional, and metabolomic).
These high-throughput next-generation sequencing (NGS) datasets are used to discern the most important molecular signatures during development and disease.
In a paper published in Genome Medicine this week, Dr. Mason shows the impact of widespead gene patents across the human [more]